Coelho Ana, Coelho Margarida, Pereira Joana, Lavrador Vasco, Morais Lurdes, Carvalho Fátima
Serviço de Cirurgia Pediátrica. Departamento da Infância e Adolescência. Centro Materno-Infantil do Norte. Centro Hospitalar do Porto. Porto. Portugal.
Serviço de Pediatria. Departamento da Infância e Adolescência. Centro Materno-Infantil do Norte. Centro Hospitalar do Porto. Porto. Portugal.
Acta Med Port. 2016 Nov;29(11):711-715. doi: 10.20344/amp.7178. Epub 2016 Nov 30.
The treatment of complicated pleural parapneumonic effusions with intrapleural instillation of fibrinolytics, has shown similar results as surgical treatment. The present study aimed to evaluate the results of the use of intrapleural instillation of fibrinolytics in the treatment of complicated pleural parapneumonic effusions, in patients followed in our hospital.
A retrospective review of all the patients (aged between one month and 18 years) diagnosed with complicated parapneumonic effusions, which had chest drain insertion with intrapleural instillation of fibrinolytic, between January 2005 and December 2013, was undertaken.
A total of 37 patients were identified. Mean duration of hospital stay was 17 ± 7.60 days. Chest drain was placed in the first 48 h of hospital admission in most of the patients (89.2%), with a mean of six days of drainage. Treatment failure was reported in 2.7% of cases and was related with effusion recurrence. This patient underwent video-assisted thoracoscopic surgery with the need to convert to open thoracotomy. A favorable outcome was achieved in 96.9 % of cases.
In our review, therapeutic success rate was as expected, with a failure rate below those reported in literature. We present intrapleural instillation of fibrinolytics and video-assisted thoracoscopic surgery as part of the same protocol, in which fibrinolytic therapy is the first-line treatment.
The therapeutic option presented shows a low failure rate and avoids a more aggressive surgical procedure. We consider this an effective treatment option, with low sequelae rate.
胸膜腔内注入纤维蛋白溶解剂治疗复杂性肺炎旁胸腔积液,已显示出与手术治疗相似的效果。本研究旨在评估在我院接受治疗的患者中,胸膜腔内注入纤维蛋白溶解剂治疗复杂性肺炎旁胸腔积液的效果。
回顾性分析2005年1月至2013年12月期间,所有诊断为复杂性肺炎旁胸腔积液、接受胸腔引流并胸膜腔内注入纤维蛋白溶解剂的患者(年龄在1个月至18岁之间)。
共确定37例患者。平均住院时间为17±7.60天。大多数患者(89.2%)在入院后的前48小时内放置胸腔引流管,平均引流6天。2.7%的病例报告治疗失败,与胸腔积液复发有关。该患者接受了电视辅助胸腔镜手术,需要转为开胸手术。96.9%的病例取得了良好的效果。
在我们的回顾中,治疗成功率符合预期,失败率低于文献报道。我们将胸膜腔内注入纤维蛋白溶解剂和电视辅助胸腔镜手术作为同一方案的一部分,其中纤维蛋白溶解剂治疗是一线治疗。
所提出的治疗方案显示出较低的失败率,避免了更激进的手术程序。我们认为这是一种有效的治疗选择,后遗症发生率低。